Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001890784-26-000006

Chief Accounting Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anand Bhaskar · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-08 Grant or award : show line 1 in the form +100,000 261,047 D
Loading xslF345X06/wk-form4_1792008434.xml…